Pfizer To Expand Reno Distribution Facility
This article was originally published in The Pink Sheet Daily
The $16 mil. expansion is “part of a strategy to strengthen western U.S. distribution capabilities,” Pfizer says. The plan is announced against the backdrop of negotiations with wholesalers over new “fee for service” contracts.
You may also be interested in...
Additional contracts have been signed with several “mid-tier” manufacturers, and three additional agreements with large manufacturers are expected in the next month. The wholesaler wants to switch 85% of its sales volume to fee-for-service.
DURHAM, N.C. - The decline in FDA's tally of new molecular entity approvals stems from fewer approvals of non-innovative products in recent years, while approvals of truly innovative products has largely held steady, according to FDA Deputy Commissioner for Policy, Planning and Preparedness Randall Lutter
Amgen's failed Anemia of Cancer trial of Aranesp and Panitumumab Advanced Colorectal Cancer Evaluation (PACCE) trial of Vectibix may illustrate the potential pitfalls facing sponsors that conduct "real world" trials of their products